Press releases
We are strong communicators and ensure you have as much relevant information at your fingertips as possible.
Press release
Stiris Research Inc. Announces the Award of a Phase II Vasculitis Study
Read more
Press release
Stiris Research Inc. Announces the First Site Initiated in a Phase II Trial in Chronic Kidney disease
Read more
Press release
Stiris Research Inc. Awarded Phase IIa Amyotrophic Lateral Sclerosis Study
Read more
Press release
Stiris Research Inc. Awarded Phase I Amyotrophic Lateral Sclerosis Study
Read more
Press release
Stiris Research Inc Announces First Site Initiation Visit in Phase III Glioblastoma Trial
Read more
Press release
Stiris Research Inc. Awarded Global Hereditary Angioedema Trial
Read more
Press release
Stiris Research Inc. Announces First Site Activated Phase Ib Amyotrophic Lateral Sclerosis Study
Read more
Press release
Stiris Research Inc. Announces the First Patient Treated In Non-Small Cell Lung Cancer Trial
Read more
Press release
Stiris Research Inc. Announces the First Site Initiated in Phase II Amyotrophic Lateral Sclerosis Trial
Read more
Press release
Stiris Research Inc. Announces the First Site Initiated In Phase I Non-Small Cell Lung Cancer Trial
Read more
Press release
Stiris Research Inc. Announces Database Lock in Phase II Hepatorenal-Syndrome Trial
Read more
Press release
A Deep Dive into the ICH GCP Revision 3: Unpacking the Digital Implications
Read more
Press release
Stiris Research Inc. Awarded Phase II Amyotrophic Lateral Sclerosis Trial
Read more
Press release
Stiris Research Inc. Announces First Patient Enrolled in Phase II Hepatorenal-Syndrome Trial
Read more
Press release
Stiris Research Inc. Awarded Phase III Glioblastoma Study
Read more
Press release
Stiris Research Inc. Awarded Phase I Non-Small Cell Lung Cancer Trial
Read more
Press release
Stiris Research Inc. Announces First Treatment-Naive Subject Screening in Phase II-III Congenital Myotonic Dystrophy Trial.
Read more
Press release
Stiris Research Inc. Announces Recruitment Closed in Phase II-III Congenital Myotonic Dystrophy Trial
Read more
Press release
Stiris Research Inc. Announces Successful Enrollment Completion in Phase II Retinal Vein Occlusion Study
Read more
Press release
Stiris Research Announces Completion of the Multiple Year Smallpox Vaccine Study
Read more
Press release
Stiris Research Inc. Announces First Patient Dosed in Phase II Retinal Vein Occlusion Study
Read more
Press release
Stiris Research Inc. Awarded Rescue Study for Hepatorenal-Syndrome
Read more
Press release
Stiris Research Inc. Awarded Phase I Metastatic Resistant Prostate Cancer Trial with Bone Metastasis Trial
Read more
Press release
Stiris Research Announces Positive Results from Zucara Therapeutics’ Phase 1b Hypoglycemic Clamp Trial
Read more
Press release
Stiris Research Inc. Announces First Patient Treated in Study Using Artificial Intelligence (AI) in Patients with Depression
Read more
Press release
Stiris Research Announces Database Lock in Phase 1b Hypoglycemic Clamp Trial
Read more
Press release
Stiris Research Inc. Announces the Addition of Fernando Lasso de la Vega, MD to the Clinical Science Team.
Read more
Press release
Stiris Research Inc. Awarded Pivotal Pre-Hospital Cardiovascular Study
Read more
Press release
Stiris Research Inc. Announces Enrollment of First Patient in Paraoxysmal Nocturnal Hemoglobinuria Study.
Read more
Press release
Stiris Research Inc. Announces First Site Initiated in Study Using Artificial Intelligence (AI) in Patients with Depression
Read more
Press release
Stiris Research Inc. Announces the First Site Initiated in Paraoxysmal Nocturnal Hemoglobinuria Studies
Read more
Press release
Stiris Research Announces First Site Initiated in COVID-19 Rescue Study
Read more
Press release
Stiris Research Inc. Announces Successful Completion of Clinical Study Report for a Phase IB Study in Uveal Melanoma
Read more
Press release
Stiris Research Inc. Announces Award of Proof-Of-Concept Study for Agitation in Autism Spectrum Disorder
Read more
Press release
Stiris Research Inc. Announces First Site Initiation in Phase II-III Congenital Myotonic Dystrophy Trial
Read more
Press release
Stiris Research Inc. Announces First Patient Enrolled in Phase II-III Congenital Myotonic Dystrophy Trial
Read more
Press release
Stiris Research Announces Completion of Patient Visits in Smallpox Study
Read more
Press release
Stiris Research Inc. Announces First Patients Dosed in Zucara’s Phase 1b Hypoglycemic Clamp Trial
Read more
Press release
Stiris Research Announces Site Initiated in Zucara’s Phase 1b Hypoglycemic Clamp Trial
Read more
Press release
Stiris Research Inc. Celebrates International Women’s Day
Read more
Press release
Stiris Research Inc. Awarded Rescue Study in COVID-19 Program
Read more
Press release
Stiris Research Inc. Awarded Phase I Clamp trial in Type 1 Diabetes Mellitus
Read more
Press release
Stiris Research Inc. Awarded 2 Global Rare Disease Studies
Read more
Press release
Stiris Research Inc. Awarded a Phase 2 Nephropathy Study
Read more
Press release
Stiris Research Inc. Phase I Study in COVID-19
Read more
Press release
Stiris Research Inc. Announces First Subjects Dosed
Read more
Press release
Stiris Research Inc. Phase I Healthy Volunteer Study in COVID-19
Read more
Press release
Stiris Research Inc. Awarded a Pilot Study Using Artificial Intelligence (AI) in Patients with Depression
Read more
Press release
Stiris Research Inc. Awarded First-in-Human, Phase I clinical trial in Type 1 Diabetes Mellitus
Read more
Press release
WEBINAR RECORDING – Centralizing Clinical Trial Activities: Can this be the New Norm?
Read more
Press release
Helping The Community During COVID-19
Read more
Press release
How are you managing stress during a global pandemic & physical distancing? The Stiris Team wants to help.
Read more
Press release
A CRA’s Perspective on Keeping Sites Engaged During COVID-19
Read more
Press release
Finding Your Feet in the Clinical Trials World During a Global Pandemic
Read more
Press release
Managing Newly Remote Teams During a Global Crisis
Read more
Press release
Stiris Research Inc. completes Phase IIa Venous Leg Ulcer Study
Read more
Press release
Stiris Research Inc. Announces Collaboration With US Biotech Company On Their Neurological Movement Disorder Trial
Read more
Press release
Stiris Research Inc. announces addition of a Director, Clinical Science
Read more
Press release
Stiris Research Inc. successful completion of their Zika Virus trial
Read more
Press release
Press Release – Stiris’ Shantal Feltham Receives YMCA Women of Excellence in Entrepreneurship
Read more
Press release
Stiris Research Inc. completes enrollment ahead of schedule on a Phase 1b Uveal Melanoma study
Read more
Press release
Stiris Research Inc. announces favourable FDA response on US pancreatic cancer program
Read more
Press release
Stiris Research Inc. collaborates with Canadian biotech to research a novel cancer therapy guidance tool
Read more
Press release
Stiris Research Inc. announces completion of Site Closeout Visits in their Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study
Read more
Press release
Stiris Research Inc. announces continued collaboration with North American biotechnology company on their Zika Virus trial
Read more
Press release
Stiris Research Inc. announces the completion of Site Closeout Visits for its Phase III trial in Parkinson’s Disease
Read more
Press release
Stiris Research Inc. hits corporate target of First Patient treated on US pancreatic cancer program
Read more
Press release
Stiris Research Inc. completes database lock on Phase III Global Parkinson’s trial
Read more
Press release
Stiris Research Inc. hits corporate target of First Patient First Visit on Phase 1b Uveal Melanoma study
Read more
Press release
Stiris Research Inc. announces First Site Initiation on Phase II Frontotemporal Dementia Study
Read more
Press release
Stiris Research Inc. awarded Phase Ib trial in Uveal Melanoma
Read more
Press release
Stiris Research Inc. completes Phase II Meniere’s disease study
Read more
Press release
Stiris Research Inc. collaborates on a Investigator Initiated Trial in Frontotemporal Dementia
Read more
Press release
Stiris Research’s CEO Shantal Feltham Voted #10 In Canada’s 15 Most Influential Female Entrepreneurs
Read more
Press release
Stiris Research Inc. awarded a Phase I Healthy Volunteer study in Parkinson’s disease
Read more
Press release
Stiris Research Inc. awarded extension of Phase II Hormone Refractory Castrate-Resistant Prostate Cancer (HRCPC) study
Read more
Press release
Stiris Research Inc. hits corporate target of First Patient Visit in a Phase III Global Parkinson’s Study
Read more
Press release
Stiris Research Inc. awarded a Phase IIa Venous Leg Ulcer Study
Read more
Press release
Stiris Research Inc. collaborates with US biotech to conduct preliminary feasibility in Non-Hodgkin’s Lymphoma
Read more
Press release
Stiris Research Inc. hits corporate target of First Site Initiation Visit in a Phase III Global Parkinson’s Study
Read more
Press release
Stiris Research Inc. completes database lock on Phase III Global Parkinson’s trial
Read more
Press release
Stiris Research Inc. exceeds recruitment targets in Phase II Meniere’s disease study
Read more
Press release
Stiris Research Inc. collaborates with US biotech to conduct their Phase III Global Parkinson’s Study
Read more
Press release
Stiris Ranks 124th on the 2016 PROFIT 500
Read more
Press release
Stiris Research’s CEO Ranks No. 9 on the W100
Read more
Press release
Stiris Research’s CEO Selected for Elite Ivey Program
Read more
Press release
Stiris Ranks 23rd on Profit/Chatelaine W100
Read more
Load More